- Home
- INM vs ZIMV Comparison
INM vs ZIMV Comparison
Compare INM & ZIMV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- ZIMV
- Stock Information
- Founded
- INM 1981
- ZIMV 2021
- Country
- INM Canada
- ZIMV United States
- Employees
- INM N/A
- ZIMV N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- ZIMV Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- INM Health Care
- ZIMV Health Care
- Exchange
- INM Nasdaq
- ZIMV Nasdaq
- Market Cap
- INM 3.2M
- ZIMV 262.9M
- IPO Year
- INM N/A
- ZIMV N/A
- Fundamental
- Price
- INM $2.98
- ZIMV $9.47
- Analyst Decision
- INM
- ZIMV Hold
- Analyst Count
- INM 0
- ZIMV 1
- Target Price
- INM N/A
- ZIMV N/A
- AVG Volume (30 Days)
- INM 54.4K
- ZIMV 135.3K
- Earning Date
- INM 05-13-2025
- ZIMV 05-08-2025
- Dividend Yield
- INM N/A
- ZIMV N/A
- EPS Growth
- INM N/A
- ZIMV N/A
- EPS
- INM N/A
- ZIMV N/A
- Revenue
- INM $4,832,013.00
- ZIMV $449,749,000.00
- Revenue This Year
- INM N/A
- ZIMV $2.13
- Revenue Next Year
- INM N/A
- ZIMV $2.44
- P/E Ratio
- INM N/A
- ZIMV N/A
- Revenue Growth
- INM N/A
- ZIMV N/A
- 52 Week Low
- INM $1.72
- ZIMV $8.56
- 52 Week High
- INM $15.70
- ZIMV $22.40
- Technical
- Relative Strength Index (RSI)
- INM 58.03
- ZIMV 40.29
- Support Level
- INM $2.85
- ZIMV $9.21
- Resistance Level
- INM $3.10
- ZIMV $9.74
- Average True Range (ATR)
- INM 0.25
- ZIMV 0.50
- MACD
- INM 0.06
- ZIMV 0.13
- Stochastic Oscillator
- INM 78.44
- ZIMV 55.49
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
About ZIMV ZimVie Inc.
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.